4//SEC Filing
BONDURANT STUART 4
Accession 0001181431-11-029016
CIK 0001484478other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 10:37 AM ET
Size
6.4 KB
Accession
0001181431-11-029016
Insider Transaction Report
Form 4
BONDURANT STUART
Director
Transactions
- Purchase
Common Stock
2011-05-11$15.25/sh+3,300$50,324→ 3,896 total
Holdings
- 17,570
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (17,570 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.24 to $15.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeother
Related Parties
1- filerCIK 0001181152
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 10:37 AM ET
- Size
- 6.4 KB